We are live on
!
Find out more
EAMA
EFG Asset Management (Americas) Portfolio holdings
AUM
$579M
1-Year Est. Return
24.22%
This Fund
S&P 500
This Quarter
Est. Return
+3.78%
1 Year Est. Return
+24.22%
3 Year Est. Return
+111.84%
5 Year Est. Return
+130.47%
10 Year Est. Return
+452.32%
AUM
$510M
AUM Growth
+$182M
(+55%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
33.25%
Top 10 Holdings %
Top 10 Hldgs %
30.6%
Holding
139
New
13
Increased
102
Reduced
7
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$9.93M |
| 2 |
Microsoft
MSFT
|
+$7.88M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.69M |
| 4 |
Apple
AAPL
|
+$4.4M |
| 5 |
Amazon
AMZN
|
+$4.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$3.32M |
| 2 |
Freeport-McMoran
FCX
|
+$2.74M |
| 3 |
Roblox
RBLX
|
+$1.3M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$1.07M |
| 5 |
Palo Alto Networks
PANW
|
+$867K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 10.68% |
| 3 | Financials | 10.14% |
| 4 | Consumer Discretionary | 9.03% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Charles River Laboratories
CRL
$12.8B
| – | – |
-750
| Closed | -$203K |
|
127
DexCom
DXCM
$32B
| – | – |
-1,692
| Closed | -$235K |
|
|
EXAS
128
DELISTED
Exact Sciences
EXAS
| – | – |
-15,511
| Closed | -$1.07M |
|
|
129
Freeport-McMoran
FCX
$97.5B
| – | – |
-58,187
| Closed | -$2.74M |
|
130
IQVIA
IQV
$39.3B
| – | – |
-1,014
| Closed | -$256K |
|
131
Neurocrine Biosciences
NBIX
$16.6B
| – | – |
-1,774
| Closed | -$245K |
|
|
132
Palo Alto Networks
PANW
$297B
| – | – |
-6,104
| Closed | -$867K |
|
|
133
Roblox
RBLX
$27B
| – | – |
-33,921
| Closed | -$1.3M |
|
134
Rocket Pharmaceuticals
RCKT
$394M
| – | – |
-7,500
| Closed | -$202K |
|
135
iShares Global REIT ETF
REET
$5.11B
| – | – |
-35,335
| Closed | -$837K |
|
136
Stryker
SYK
$130B
| – | – |
-703
| Closed | -$252K |
|
137
Veracyte
VCYT
$3.8B
| – | – |
-9,065
| Closed | -$201K |
|
138
Zoetis
ZTS
$30B
| – | – |
-1,221
| Closed | -$207K |
|
|
SWAV
139
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-994
| Closed | -$324K |
|
Similar funds
CCME
FA
FCP
AWAM
BTWM
SFPM
GP
PWM
EFG Asset Management (Americas)'s Q2 2024 Portfolio in Review
As of Q2 2024, EFG Asset Management (Americas) held 139 positions worth $510M, up 55% from $329M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
EFG Asset Management (Americas) deployed $170M of net new capital in Q2 2024, opening 13 new positions and adding to 102 existing holdings. Its largest new stake was NVIDIA: 98,257 shares worth $12.1M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Chipotle Mexican Grill, an estimated $291K trimmed.
- EFG Asset Management (Americas)'s largest Q2 2024 buy was NVIDIA: 98,257 shares worth $12.1M.
- EFG Asset Management (Americas) added most to Microsoft in Q2 2024, an estimated $7.88M increase.
- EFG Asset Management (Americas)'s biggest Q2 2024 reduction was Chipotle Mexican Grill, cutting an estimated $291K.
- EFG Asset Management (Americas) fully exited Applied Materials in Q2 2024, selling an estimated $3.32M.
- EFG Asset Management (Americas)'s ten largest holdings make up 31% of its $510M portfolio in Q2 2024.
- EFG Asset Management (Americas) opened 13 new positions and closed 16 in Q2 2024.
- EFG Asset Management (Americas)'s portfolio value rose 55% quarter-over-quarter to $510M.
Based on EFG Asset Management (Americas)'s 13F filing for Q2 2024, filed 6 Aug 2024.